Free Trial

Ensign Peak Advisors Inc Grows Holdings in DaVita Inc. (NYSE:DVA)

DaVita logo with Medical background

Ensign Peak Advisors Inc raised its stake in DaVita Inc. (NYSE:DVA - Free Report) by 57.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 31,292 shares of the company's stock after purchasing an additional 11,395 shares during the quarter. Ensign Peak Advisors Inc's holdings in DaVita were worth $4,680,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in the stock. United Capital Financial Advisors LLC boosted its holdings in DaVita by 2.6% in the fourth quarter. United Capital Financial Advisors LLC now owns 2,416 shares of the company's stock valued at $361,000 after acquiring an additional 62 shares during the last quarter. Freedom Investment Management Inc. raised its holdings in shares of DaVita by 3.6% in the 4th quarter. Freedom Investment Management Inc. now owns 1,790 shares of the company's stock worth $268,000 after purchasing an additional 62 shares during the period. Exchange Traded Concepts LLC lifted its stake in shares of DaVita by 8.3% in the 4th quarter. Exchange Traded Concepts LLC now owns 891 shares of the company's stock valued at $133,000 after purchasing an additional 68 shares in the last quarter. Impact Partnership Wealth LLC grew its holdings in shares of DaVita by 3.7% during the 4th quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company's stock worth $290,000 after purchasing an additional 70 shares during the period. Finally, Contravisory Investment Management Inc. increased its position in DaVita by 1.2% during the 4th quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company's stock worth $910,000 after purchasing an additional 73 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on DVA shares. Truist Financial reduced their price target on shares of DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a research report on Monday. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. Barclays upped their price target on shares of DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 18th. StockNews.com raised DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. Finally, Cowen reaffirmed a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, DaVita presently has an average rating of "Hold" and a consensus price target of $164.50.

Get Our Latest Report on DVA

DaVita Stock Up 1.7%

Shares of DVA stock traded up $2.48 on Tuesday, hitting $147.44. The stock had a trading volume of 146,003 shares, compared to its average volume of 828,244. The stock's 50 day moving average is $145.72 and its 200-day moving average is $153.60. The firm has a market capitalization of $11.13 billion, a price-to-earnings ratio of 13.70, a P/E/G ratio of 1.07 and a beta of 1.14. DaVita Inc. has a 52-week low of $131.44 and a 52-week high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $2.00 EPS for the quarter, topping analysts' consensus estimates of $1.75 by $0.25. The firm had revenue of $3.22 billion for the quarter, compared to analyst estimates of $3.22 billion. DaVita had a net margin of 7.31% and a return on equity of 115.48%. The firm's revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.26 EPS. As a group, research analysts expect that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Featured Articles

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Should You Invest $1,000 in DaVita Right Now?

Before you consider DaVita, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.

While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress Is POURING Into This Stock
The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines